Loading…
Loading…
TRUL does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TRUL and 80,000+ other tickers.
See exactly how TRUL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TRUL and 80,000+ other tickers.
Trulite, Inc. is a development-stage enterprise focused on the design, production, procurement, promotion, and sale of power generation solutions. These encompass portable, semi-portable, and stationary devices, components, and integrated systems primarily for off-grid applications within the United States. The company's product portfolio features hydrogen fuel cells, solar photovoltaic panels, small-scale wind turbines, batteries, charge controllers, and power inverters. A notable offering is the HydroCell, which utilizes a chemical hydride cartridge to produce hydrogen on demand when…
Since launching in Florida's medical cannabis market in 2015, Trulieve Cannabis (CSE:TRUL) has grown its operations to encompass a total of nine states across the U.S., expanding its team from 10 members to more than 6,000 and surpassing US$1 billion in revenue. The company now operates the world's largest retail network of cannabis dispensaries, not to mention more than 4 million square feet of domestic cultivation facilities, with 3 million square feet of that in Florida.
The Biden administration's official move to reschedule cannabis has been welcomed by Kim Rivers, the CEO of Florida-focused cannabis multi-state operator Trulieve Cannabis Corp. (CSE:TRUL). US President Joe Biden on Thursday confirmed that the Justice Department would be advancing the proposal to reclassify marijuana as a lower-risk Schedule III drug, instead of Schedule I, where it currently sits alongside heroin and fentanyl.